teriparatide vs semaglutide GLP-1 Receptor Agonist Research Reference Switching Semaglutide to Tirzepatide: A

,

References 1.Tsapas A, Avgerinos I, Karagiannis T, et al

Frequently Asked Questions (FAQs) Learn more about Ozempic and blindness with answers to these frequently asked questions

If you are experiencing a mental health crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911.

The most widely prescribed GLP-1 RAs for weight management include: Semaglutide sold as Ozempic (diabetes) and Wegovy (weight loss), administered by weekly subcutaneous injection Tirzepatide sold as Mounjaro (diabetes) and Zepbound (weight loss), a dual GIP/GLP-1 agonist administered by weekly injection Liraglutide sold as Saxenda (weight loss) and Victoza (diabetes), administered by daily injection GLP-1 RAs were originally developed as diabetes treatments but have become widely used for obesity and weight management following large clinical trials showing substantial weight loss outcomes